Response to: ‘Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’’ by Zou et al | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Correspondence response

Response to: ‘Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’’ by Zou et al

Online download statistics by month:

Online download statistics by month: January 2021 to April 2023

	Abstract	Full	Pdf
Jan 2021	188	185	35
Feb 2021	241	240	49
Mar 2021	122	122	40
Apr 2021	35	35	45
May 2021	108	109	37
Jun 2021	46	46	41
Jul 2021	62	62	45
Aug 2021	43	43	30
Sep 2021	42	42	28
Oct 2021	52	51	52
Nov 2021	39	39	32
Dec 2021	101	103	27
Jan 2022	49	49	119
Feb 2022	45	45	32
Mar 2022	29	29	28
Apr 2022	43	43	36
May 2022	34	34	33
Jun 2022	35	35	29
Jul 2022	43	43	29
Aug 2022	39	40	27
Sep 2022	29	29	25
Oct 2022	28	29	30
Nov 2022	25	25	18
Dec 2022	29	28	9
Jan 2023	35	35	18
Feb 2023	28	28	11
Mar 2023	525	22	24
Apr 2023	239	22	28
Total	2334	1613	957